Dissemin is shutting down on January 1st, 2025

Published in

Springer (part of Springer Nature), Cardiovascular Drugs and Therapy, 6(21), p. 467-469

DOI: 10.1007/s10557-007-6067-6

Links

Tools

Export citation

Search in Google Scholar

The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore

Journal article published in 2007 by Sy Y. Lim ORCID, Sm M. Davidson, Mm M. Mocanu, Dm M. Yellon, Cct C. T. Smith
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Necrostatin (Nec-1) protects against ischemia-reperfusion (IR) injury in both brain and heart. We have previously reported in this journal that necrostatin can delay opening of the mitochondrial permeability transition pore (MPTP) in isolated cardiomyocytes. The aim of the present study was to investigate in more detail the role played by the MPTP in necrostatin-mediated cardioprotection employing mice lacking a key component of the MPTP, namely cyclophilin-D. Anaesthetized wild type (WT) and cyclophilin-D knockout (Cyp-D-/-) mice underwent an open-chest procedure involving 30 minutes of myocardial ischemia and 2 hours of reperfusion, with subsequent infarct size assessed by triphenyltetrazolium staining. Nec-1, given at reperfusion, significantly limited infarct size in WT mice (17.7±3% vs. 54.3±3%, P0.05). In conclusion, the data obtained in Cyp-D−/− mice provide further evidence that Nec-1 protects against myocardial IR injury by modulating MPTP opening at reperfusion.